• OPEN AN ACCOUNT
Indian Indices
Sensex
76,515.43 362.57
( 0.48%)
Global Indices
Nasdaq
53,682.77 599.82
(1.13%)
Dow Jones
7,765.55 77.95
(1.01%)
Hang Seng
65,002.68 788.20
(1.23%)
Nikkei 225
10,831.87 75.42
(0.70%)
Forex
USD-INR
94.73 -0.22
(-0.23%)
EUR-INR
109.71 -0.40
(-0.36%)
GBP-INR
127.83 -0.65
(-0.50%)
JPY-INR
0.59 0.00
(0.14%)

EQUITY - MARKET SCREENER

Curis Lifesciences Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
94348
INE1BZN01016
58.5748291
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CURIS
16.93
117.31
EPS(TTM)
Face Value()
Div & Yield %
8.57
10
0
 

Real Growth Corporation standalone net profit declines 88.50% in the March 2026 quarter
May 26,2026
Net profit of Real Growth Corporation declined 88.50% to Rs 0.85 crore in the quarter ended March 2026 as against Rs 7.39 crore during the previous quarter ended March 2025. There were no Sales reported in the quarter ended March 2026 as against Rs 3.80 crore during the previous quarter ended March 2025.

For the full year,net profit declined 89.42% to Rs 0.77 crore in the year ended March 2026 as against Rs 7.28 crore during the previous year ended March 2025. Sales declined 93.16% to Rs 0.26 crore in the year ended March 2026 as against Rs 3.80 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales03.80 -100 0.263.80 -93
OPM %0-26.05 --338.46-48.68 -
PBDT1.291.85 -30 1.021.74 -41
PBT1.291.85 -30 1.021.74 -41
NP0.857.39 -88 0.777.28 -89